LONGITUDINAL MONITORING OF HAEMATOLOGICAL CANCERS IN THE UK: THE HAEMATOLOGICAL MALIGNANCY

With diverse etiologies, treatment pathways and outcomes, hematological malignancies comprise a heterogeneous group of over 60 cancers.1,2 Critically for epidemiology, appreciation of the similarities and differences within this complex cancer group only emerged in recent decades, as understanding about the relationship between the various hematological malignancies, the bone marrow, the immune system and the cellular and genetic basis of malignant transformation gradually increased.